Search results
30 lip 2024 · The main focus is on the therapeutic use of psychedelics, but the FAQs also provide information about prevalence and patterns of use, the presence of unlicensed and illegal psychedelic practices, and developments in clinical research.
The Johns Hopkins Center for Psychedelic and Consciousness Research is leading the way in exploring innovative treatments using psilocybin.
17 sie 2020 · We used a broad definition of psychedelics that included a range of pharmacologically diverse substances: the ‘classical’ serotonergic psychedelics psilocybin, LSD, and ayahuasca; MDMA; ibogaine; and ketamine, which were used to treat several distinct mental disorders.
17 maj 2017 · Since the early 1990s, there has been a steady revival of human psychedelic research: last year saw reports on the first modern brain imaging study with LSD and three separate clinical trials of psilocybin for depressive symptoms.
Dr. Alan Davis is an Associate Professor and Director of the Center for Psychedelic Drug Research and Education in the College of Social Work at the Ohio State University and Adjunct Professor at Johns Hopkins. Their research involves the exploration of psychedelic substance use in community, ceremonial/spiritual, and clinical settings.
26 lut 2020 · The most significant database exists for MDMA and psilocybin, which have been designated by the U.S. Food and Drug Administration (FDA) as “breakthrough therapies” for posttraumatic stress disorder (PTSD) and treatment-resistant depression, respectively.
13 lis 2023 · Psychedelic medications are a class of chemicals that alter or improve sensory perceptions, mental processes, and vigour. Mescaline, psilocybin, dimethyltryptamine (DMT), and d-lysergic acid dimethylamine (LSD) are examples of traditional psychedelic drugs.
